ABIN320004
antibody from antibodies-online
Targeting: CD59
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN320004 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD59 (CD59) antibody
- Antibody type
- Monoclonal
- Description
- Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
- Reactivity
- Human
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- YTH53-1
- Vial size
- 25 μg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Complement susceptibility in glutamine deprived breast cancer cells.
Identification of MIC 11 antigen as an epitope of the CD59 molecule.
Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement.
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
Ellison BS, Zanin MK, Boackle RJ
Cell division 2007 Jul 11;2:20
Cell division 2007 Jul 11;2:20
Identification of MIC 11 antigen as an epitope of the CD59 molecule.
Davies A, Wilson AB, Bramley JC, Willers C, Van Heyningen V, Bickmore WA, Lachmann PJ
Immunology 1995 Jun;85(2):220-7
Immunology 1995 Jun;85(2):220-7
Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement.
Walsh LA, Tone M, Waldmann H
European journal of immunology 1991 Mar;21(3):847-50
European journal of immunology 1991 Mar;21(3):847-50
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H
The Journal of experimental medicine 1989 Sep 1;170(3):637-54
The Journal of experimental medicine 1989 Sep 1;170(3):637-54
No comments: Submit comment
No validations: Submit validation data